The question “are we learning anything new?” keeps being asked when related to comprehensive gene analysis of tumours. This Review attempts to answer that question, and describes how new targets are being identified and how that knowledge is being translated into the clinic.
- Eric A. Collisson
- Raymond J. Cho
- Joe W. Gray
